Maurice Hilleman The Chief Of The Dept. Of Virus Diseases, Walter Reed Army Medical Center
Maurice Hilleman
Born
August 30, 1919
DiedApril 11, 2005 (aged 85)
NationalityAmericanAlma materMontana State University
University of ChicagoOccupationMicrobiologist, vaccinologistKnown forDeveloping several important vaccinesSpouse(s)
Children:- 2
Awards ;-
- National Medal of Science (1988)
- Robert Koch Prize (Gold, 1989)
- Albert B. Sabin Gold Medal (1997)
- Prince Mahidol Award (2002)
Biography
Hilleman was born on a farm near the high plains town of Miles City, Montana. His parents were Anna (Uelsmann) and Gustav Hillemann, and he was their eighth child. His twin sister died when he was born, and his mother died two days later. He was raised in the nearby household of his uncle, Bob Hilleman, and worked in his youth on the family farm. He credited much of his success to his work with chickens as a boy; since the 1930s, fertile chicken eggs had often been used to grow viruses for vaccines.
His family belonged to the Lutheran Church–Missouri Synod. When he was in the eighth grade, he discovered Charles Darwin, and was caught reading On the Origin of Species in church. Later in life, he rejected religion. Due to lack of money, he almost failed to attend college. His eldest brother interceded, and Hilleman graduated first in his class in 1941 from Montana State University with family help and scholarships. He won a fellowship to the University of Chicago and received his doctoral degree in microbiology in 1944. His doctoral thesis was on chlamydia infections, which were then thought to be caused by a virus. Hilleman showed that these infections were, in fact, caused by a species of bacterium, Chlamydia trachomatis, that grows only inside of cells.
After joining E.R. Squibb & Sons (now Bristol-Myers Squibb), Hilleman developed a vaccine against Japanese B encephalitis, a disease that threatened American troops in the Pacific Ocean theater of World War II. As chief of the Department of Respiratory Diseases at Army Medical Center (now the Walter Reed Army Institute of Research) from 1948 to 1957, Hilleman discovered the genetic changes that occur when the influenza virus mutates, known as antigenic shift and antigenic drift, which he theorized would mean that a yearly influenza vaccination would be required.
In 1957, Hilleman joined Merck & Co. (Kenilworth, New Jersey), as head of its new virus and cell biology research department in West Point, Pennsylvania. It was while with Merck that Hilleman developed most of the forty experimental and licensed animal and human vaccines with which he is credited, working both at the laboratory bench as well as providing scientific leadership.
Hilleman served on numerous national and international advisory boards and committees, academic, governmental and private, including the National Institutes of Health's Office of AIDS Research Program Evaluation and the Advisory Committee on Immunization Practices of the National Immunization Program.
Hilleman was among the first to recognize that a 1957 outbreak of influenza in Hong Kong could become a huge pandemic. Working on a hunch, after nine 14-hour days he and a colleague found that it was a new strain of flu that could kill millions. Forty million doses of vaccines were prepared and distributed. Although 69,000 Americans died, the pandemic could have resulted in many more deaths in the United States. Hilleman was awarded the Distinguished Service Medal from the American military for his work. His vaccine is believed to have saved hundreds of thousands of lives.
In 1968, during the Hong Kong flu pandemic, Hilleman and his team also played a key role in developing a vaccine, and nine million doses became available in 4 months.
Hilleman was one of the early vaccine pioneers to warn about the possibility that simian viruses might contaminate vaccines. The best-known of these viruses became SV40, a viral contaminant of the polio vaccine, whose discovery led to the recall of Salk's vaccine in 1961 and its replacement with Albert Sabin's oral vaccine. The contamination actually occurred in both vaccines at very low levels, but because the oral vaccine was ingested rather than injected, it did not result in infections or any harm.
In 1963, his daughter Jeryl Lynn came down with the mumps. He cultivated material from her, and used it as the basis of a mumps vaccine. The Jeryl Lynn strain of the mumps vaccine is still used today. The strain is currently used in the trivalent (measles, mumps and rubella) MMR vaccine that he also developed, the first vaccine ever approved incorporating multiple live virus strains. Like many other vaccines and medications of that time period, the vaccine was initially tested in children with intellectual disabilities who lived in group homes; this was because, given the poor hygiene and cramped quarters of their accommodations, they were at much higher risk of infectious disease.
He and his group invented a vaccine for hepatitis B by treating blood serum with pepsin, urea and formaldehyde. This was licensed in 1981, but withdrawn in 1986 in the United States when it was replaced by a vaccine that was produced in yeast. The latter vaccine is still in use today. By 2003, 150 countries were using it and the incidence of the disease in the United States in young people had decreased by 95%. Hilleman considered his work on this vaccine to be his single greatest achievement. Liver transplant pioneer Thomas Starzl said "...controlling the hepatitis B virus scourge ranks as one of the most outstanding contributions to human health of the twentieth century...Maurice removed one of the most important obstacles to the field of organ transplantation".
In his later life, Hilleman was an adviser to the World Health Organization. He retired as senior vice president of the Merck Research Labs in 1984 at the mandatory retirement age of 65. He then directed the newly created Merck Institute for Vaccinology where he worked for the next twenty years until his death in 2005.
At the time of his death in Philadelphia on April 11, 2005,at the age of 85, Hilleman was Adjunct Professor of Pediatrics at the University of Pennsylvania in Philadelphia.
Comments
Post a Comment